Product Information

FT CHEST CONGEST 400 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0653 per EA under NDC 70677105401. Its NADAC has been published 152 times since Sep 27, 2023.

FT CHEST CONGEST 400 MG CAPLET

Guaifenesin
$0.0653per EA
OTC

Strength

400 mg/1

NDC

70677105401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GUAIFENESIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/27/2023

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions

Price Statistics

The NADAC for FT CHEST CONGEST 400 MG CAPLET has been published 152 times since Sep 27, 2023, and over the history we have for it it has declined 10.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0653 per EA
All-time high$0.0744 (Nov 13, 2024)
All-time low$0.0644 (Oct 18, 2023)
52-week high$0.0683
52-week low$0.0653
Median price$0.0682
Average price$0.0684
Largest weekly change-11.2% (Oct 18, 2023)
Weeks tracked152
Tracking sinceSep 27, 2023

Price History

1W

-2.1%

1M

-2.1%

3M

-2.9%

6M

-1.3%

1Y

-3.7%

3Y

N/A

5Y

N/A

All

-10.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT CHEST CONGEST 400 MG CAPLET?

The current National Average Drug Acquisition Cost (NADAC) for FT CHEST CONGEST 400 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0653 per EA (NDC 70677105401), effective Aug 19, 2026.

How has the price of FT CHEST CONGEST 400 MG CAPLET changed over time?

Over the history we have for it, the NADAC for FT CHEST CONGEST 400 MG CAPLET has declined 10.1%. It has been tracked across 152 weekly CMS publications since Sep 27, 2023.

What are the highest and lowest recorded NADAC prices for FT CHEST CONGEST 400 MG CAPLET?

Since Sep 27, 2023, the NADAC for FT CHEST CONGEST 400 MG CAPLET has ranged from a low of $0.0644 (Oct 18, 2023) to a high of $0.0744 (Nov 13, 2024), with a median of $0.0682 per EA.

Are there cheaper alternatives to FT CHEST CONGEST 400 MG CAPLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT CHEST CONGEST 400 MG CAPLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FT CHEST CONGEST 400 MG CAPLET?

FT CHEST CONGEST 400 MG CAPLET (NDC 70677105401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.